Youth Depression Research Study
Researchers at Mayo Clinic are studying the feasibility, safety, and benefits of a new form of TMS treatment for suicidal ideation in adolescents with major depressive disorder.
Fast Facts
Child Ages 12-18
Diagnosed with Depression
Compensation Provided
Conducted in Rochester, Minnesota
Study Background
Researchers at Mayo Clinic are studying an investigational treatment called sequential bilateral accelerated theta burst stimulation.
Study Background
Additional Information
You and your child may qualify for this study if you meet the following criteria.
Inclusion Criteria:
- Ages 12-18
- Diagnosed with depression
- Display signs of suicidal ideation
- No history of seizures
- No active substance use (e.g., nicotine, opioids, meth, cocaine)
- Not taking antipsychotic medication (e.g., Risperdal, Zyprexa, Seroquel)
- No taking stimulant medication (e.g., Ritalin, Concerta, Adderall)
If you and your child participate in this study, here is what you can expect:
- During the treatment part of the study, you will have a screening and baseline visit, followed by 10 days of treatment, and finally a post treatment day.
- Each of these visit days are in person and could take up to 5 hours.
- Participation involves completing baseline assessment forms, brain measures, 10 days of treatment with TMS or a sham stimulation, talk therapy, and monthly follow up visits for one year.
- The follow-up appointments can be completed virtually.
Participants are paid $50 for the baseline day, $10 for each treatment day, $50 for the post-treatment day, and $10 for each monthly follow up visit. Participants can earn up to $320 if they complete all study visits.
There is no cost to be in the study, but costs of accommodations and travel is not reimbursed by the study.
